Companies Cryptocurrencies
Aduro Biotech Inc
Aduro Biotech Inc
Exchange: Nasdaq Global Select
IPO Date:
CEO: Mr. Stephen Isaacs
Biotechnology Healthcare 🔗
  • KDNY
    symbol
  • 12.94
    price
  • 579708096
    market cap
  • 0.04999924
    changes
If you bought

shares of Aduro Biotech Inc (KDNY) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. The company is headquartered in Berkeley, California and currently employs 152 full-time employees. The firm’s product candidates from its Live, Attenuated, Double-Deleted (LADD) Listeria monocytogenes, Stimulator of Interferon Genes Pathway Activator, and B-select monoclonal antibody platforms are designed to stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies, as well as other immunotherapies. Its LADD technology platform is being developed as a treatment for multiple indications, including mesothelioma, ovarian, gastric, lung and prostate cancers. Its LADD product candidate is CRS-207, which is being developed as a treatment for multiple indications, including mesothelioma, ovarian and gastric cancers. ADU-214 and ADU-741 are product candidates in development for lung and prostate cancers, respectively.

Address: 740 Heinz Ave Berkeley CALIFORNIA 94710-2224

Stay updated.